Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Long-acting antiretroviral therapy effectiveness and patient satisfaction using patient questionnaires: data from a real-world setting ; volume:24 ; number:1 ; day:16 ; month:9 ; year:2024 ; pages:1-8 ; date:12.2024
BMC infectious diseases ; 24, Heft 1 (16.9.2024), 1-8, 12.2024
- Urheber
-
Konishi, Keiji
Onozuka, Daisuke
Okubo, Moeka
Kasamatsu, Yu
Kutsuna, Satoshi
Shirano, Michinori
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-024-09904-x
- URN
-
urn:nbn:de:101:1-2411292059146.182401909781
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Konishi, Keiji
- Onozuka, Daisuke
- Okubo, Moeka
- Kasamatsu, Yu
- Kutsuna, Satoshi
- Shirano, Michinori
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-Acting Reversible Contraception
Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Creation of a long-acting nanoformulated dolutegravir
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
Long-Acting Reversible Contraception
Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Creation of a long-acting nanoformulated dolutegravir
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
Long-Acting Reversible Contraception
Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda
Creation of a long-acting nanoformulated dolutegravir
Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages